Short answer The FDA has stepped in because many pharmacies were making unapproved “copies” of brand GLP‑1 drugs (semaglutide, tirzepatide, etc.) from bulk active ingredients. The agency says that practice can be illegal and unsafe if the compounders aren’t following the specific rules for compounding or are using non‑approved bulk drug substances. As a result the FDA has issued warning letters and public safety notices and asked some compounders to stop making these products. Legally available options now: (1) FDA‑approved GLP‑1 medicines from the drug makers (e.g., Novo Nordisk and Eli Lilly products), and (2) compounding pharmacies or outsourcing facilities that meet the law’s strict requirements (registered 503B outsourcing facilities or state‑licensed 503A pharmacies compounding for a valid individual prescription). Many compounding pharmacies stopped or limited GLP‑1 compounding after the FDA actions. More detail (plain language) What triggered the FDA action High consumer demand for GLP‑1s created a market for cheaper, compounded versions made from bulk APIs (often sourced abroad). The FDA’s concerns: some compounders were making near‑identical copies of approved drugs (which generally isn’t allowed), using bulk drug substances that aren’t permitted for compounding, or lacking adequate quality controls. That raises risks from wrong potency, contamination, sterility failures, etc. The FDA responded with public guidance, warning letters, and enforcement actions against compounders that didn’t meet legal/quality requirements. How compounding law works (short) 503A pharmacies (traditional compounding): may compound for an individual patient pursuant to a prescription, but they generally cannot make an “essentially a copy” of an FDA‑approved drug or use bulk drug substances unless allowed by law/state rules. 503B outsourcing facilities: register with FDA, follow current Good Manufacturing Practices (cGMP), can make larger batches, and are inspected by FDA — but they still must follow statutory limits (and the FDA scrutinizes use of bulk APIs and copies of approved drugs). State boards of pharmacy also regulate compounding pharmacies. Who is still operating legally FDA‑approved manufacturers and their supply chain: use the brand products approved and made by the drug companies (safe/legal). Examples: Novo Nordisk (Ozempic, Wegovy, Rybelsus) and Eli Lilly (Mounjaro, Zepbound). These are manufactured under strict quality controls and FDA approval. Licensed prescribers (PCPs, endocrinologists) and pharmacies dispensing the brand products — legal and recommended. Some compounding pharmacies and 503B outsourcing facilities continue to operate legally by following the law: they only compound when there’s a valid individual prescription and medical need, or by complying with registration/cGMP rules. After FDA actions many labs stopped compounding GLP‑1s or tightened procedures. What you should avoid: buying compounded GLP‑1s from unknown online sellers, social‑media sellers, or pharmacies that cannot prove their legal status and quality testing. If you’re considering a compounded product — what to ask and check Ask the pharmacy for: Whether they’re a 503B outsourcing facility registered with FDA (ask for registration/inspection status) or a 503A pharmacy operating under a licensed pharmacist with a patient‑specific prescription. Certificates of analysis (COA) for the active ingredient showing identity and purity. Sterility and potency testing results for the finished batch. State pharmacy license and any recent FDA warning letters or state board actions. If they can’t provide that documentation, don’t use the product. Practical recommendation (safe choices) Prefer FDA‑approved products made by the manufacturers: Novo Nordisk (Ozempic, Wegovy, Rybelsus) and Eli Lilly (Mounjaro for diabetes; Zepbound for weight loss). These are regulated, labeled, and tested. For prescriptions and access, work with your primary care doctor or a reputable telehealth or specialty clinic that prescribes and dispenses through licensed pharmacies (examples of established telehealth providers: One Medical, PlushCare, or established weight‑management clinics). Make sure they fill prescriptions through legitimate pharmacies that supply brand products or, if they recommend a compound, can provide the documentation above. If you want, I can Look up whether a specific compounding pharmacy (name) has an FDA warning letter or is registered as a 503B outsourcing facility. Explain how to check FDA warning letters and state board records yourself.
Read full answer with sources →Best Compounded GLP-1s
Compounded semaglutide and tirzepatide programs, their safety reputation, and which providers AI engines treat as trustworthy.
As of Oct 28, 2026, the Compounded GLP-1s brands AI engines recommend most are Hims & Hers, Ro, and Novo Nordisk. Hims & Hers leads with 63% AI visibility across ChatGPT, Claude, Perplexity, and Google AI.
| # | Brand | AI visibility | Trend | Avg position | Mentions | History |
|---|---|---|---|---|---|---|
| 1 | 63.2% | ▼ 6.0 pp | 2.1 | 12 | ||
| 2 | 52.6% | ▼ 1.2 pp | 2.2 | 10 | ||
| 3 | 47.4% | ▲ 8.9 pp | 4.4 | 9 | ||
| 4 | 31.6% | ▲ 0.8 pp | 3.5 | 6 | ||
| 5 | 31.6% | ▲ 0.8 pp▲ 1 place | 5.2 | 6 | ||
Unlock the full Compounded GLP-1s leaderboard 483 more ranked brands, plus every other category. Free, one email, no spam. | ||||||
| 6 | ||||||
| 7 | ||||||
| 8 | ||||||
| 9 | ||||||
| 10 | ||||||
| 11 | ||||||
| 12 | ||||||
| 13 | ||||||
| 14 | ||||||
| 15 | ||||||
| 16 | ||||||
| 17 | ||||||
| 18 | ||||||
| 19 | ||||||
| 20 | ||||||
| 21 | ||||||
| 22 | ||||||
| 23 | ||||||
| 24 | ||||||
| 25 | ||||||
| 26 | ||||||
| 27 | ||||||
| 28 | ||||||
| 29 | ||||||
| 30 | ||||||
| 31 | ||||||
| 32 | ||||||
| 33 | ||||||
| 34 | ||||||
| 35 | ||||||
| 36 | ||||||
| 37 | ||||||
| 38 | ||||||
| 39 | ||||||
| 40 | ||||||
| 41 | ||||||
| 42 | ||||||
| 43 | ||||||
| 44 | ||||||
| 45 | ||||||
| 46 | ||||||
| 47 | ||||||
| 48 | ||||||
| 49 | ||||||
| 50 | ||||||
| 51 | ||||||
| 52 | ||||||
| 53 | ||||||
| 54 | ||||||
| 55 | ||||||
| 56 | ||||||
| 57 | ||||||
| 58 | ||||||
| 59 | ||||||
| 60 | ||||||
| 61 | ||||||
| 62 | ||||||
| 63 | ||||||
| 64 | ||||||
| 65 | ||||||
| 66 | ||||||
| 67 | ||||||
| 68 | ||||||
| 69 | ||||||
| 70 | ||||||
| 71 | ||||||
| 72 | ||||||
| 73 | ||||||
| 74 | ||||||
| 75 | ||||||
| 76 | ||||||
| 77 | ||||||
| 78 | ||||||
| 79 | ||||||
| 80 | ||||||
| 81 | ||||||
| 82 | ||||||
| 83 | ||||||
| 84 | ||||||
| 85 | ||||||
| 86 | ||||||
| 87 | ||||||
| 88 | ||||||
| 89 | ||||||
| 90 | ||||||
| 91 | ||||||
| 92 | ||||||
| 93 | ||||||
| 94 | ||||||
| 95 | ||||||
| 96 | ||||||
| 97 | ||||||
| 98 | ||||||
| 99 | ||||||
| 100 | ||||||
| 101 | ||||||
| 102 | ||||||
| 103 | ||||||
| 104 | ||||||
| 105 | ||||||
| 106 | ||||||
| 107 | ||||||
| 108 | ||||||
| 109 | ||||||
| 110 | ||||||
| 111 | ||||||
| 112 | ||||||
| 113 | ||||||
| 114 | ||||||
| 115 | ||||||
| 116 | ||||||
| 117 | ||||||
| 118 | ||||||
| 119 | ||||||
| 120 | ||||||
| 121 | ||||||
| 122 | ||||||
| 123 | ||||||
| 124 | ||||||
| 125 | ||||||
| 126 | ||||||
| 127 | ||||||
| 128 | ||||||
| 129 | ||||||
| 130 | ||||||
| 131 | ||||||
| 132 | ||||||
| 133 | ||||||
| 134 | ||||||
| 135 | ||||||
| 136 | ||||||
| 137 | ||||||
| 138 | ||||||
| 139 | ||||||
| 140 | ||||||
| 141 | ||||||
| 142 | ||||||
| 143 | ||||||
| 144 | ||||||
| 145 | ||||||
| 146 | ||||||
| 147 | ||||||
| 148 | ||||||
| 149 | ||||||
| 150 | ||||||
| 151 | ||||||
| 152 | ||||||
| 153 | ||||||
| 154 | ||||||
| 155 | ||||||
| 156 | ||||||
| 157 | ||||||
| 158 | ||||||
| 159 | ||||||
| 160 | ||||||
| 161 | ||||||
| 162 | ||||||
| 163 | ||||||
| 164 | ||||||
| 165 | ||||||
| 166 | ||||||
| 167 | ||||||
| 168 | ||||||
| 169 | ||||||
| 170 | ||||||
| 171 | ||||||
| 172 | ||||||
| 173 | ||||||
| 174 | ||||||
| 175 | ||||||
| 176 | ||||||
| 177 | ||||||
| 178 | ||||||
| 179 | ||||||
| 180 | ||||||
| 181 | ||||||
| 182 | ||||||
| 183 | ||||||
| 184 | ||||||
| 185 | ||||||
| 186 | ||||||
| 187 | ||||||
| 188 | ||||||
| 189 | ||||||
| 190 | ||||||
| 191 | ||||||
| 192 | ||||||
| 193 | ||||||
| 194 | ||||||
| 195 | ||||||
| 196 | ||||||
| 197 | ||||||
| 198 | ||||||
| 199 | ||||||
| 200 | ||||||
| 201 | ||||||
| 202 | ||||||
| 203 | ||||||
| 204 | ||||||
| 205 | ||||||
| 206 | ||||||
| 207 | ||||||
| 208 | ||||||
| 209 | ||||||
| 210 | ||||||
| 211 | ||||||
| 212 | ||||||
| 213 | ||||||
| 214 | ||||||
| 215 | ||||||
| 216 | ||||||
| 217 | ||||||
| 218 | ||||||
| 219 | ||||||
| 220 | ||||||
| 221 | ||||||
| 222 | ||||||
| 223 | ||||||
| 224 | ||||||
| 225 | ||||||
| 226 | ||||||
| 227 | ||||||
| 228 | ||||||
| 229 | ||||||
| 230 | ||||||
| 231 | ||||||
| 232 | ||||||
| 233 | ||||||
| 234 | ||||||
| 235 | ||||||
| 236 | ||||||
| 237 | ||||||
| 238 | ||||||
| 239 | ||||||
| 240 | ||||||
| 241 | ||||||
| 242 | ||||||
| 243 | ||||||
| 244 | ||||||
| 245 | ||||||
| 246 | ||||||
| 247 | ||||||
| 248 | ||||||
| 249 | ||||||
| 250 | ||||||
| 251 | ||||||
| 252 | ||||||
| 253 | ||||||
| 254 | ||||||
| 255 | ||||||
| 256 | ||||||
| 257 | ||||||
| 258 | ||||||
| 259 | ||||||
| 260 | ||||||
| 261 | ||||||
| 262 | ||||||
| 263 | ||||||
| 264 | ||||||
| 265 | ||||||
| 266 | ||||||
| 267 | ||||||
| 268 | ||||||
| 269 | ||||||
| 270 | ||||||
| 271 | ||||||
| 272 | ||||||
| 273 | ||||||
| 274 | ||||||
| 275 | ||||||
| 276 | ||||||
| 277 | ||||||
| 278 | ||||||
| 279 | ||||||
| 280 | ||||||
| 281 | ||||||
| 282 | ||||||
| 283 | ||||||
| 284 | ||||||
| 285 | ||||||
| 286 | ||||||
| 287 | ||||||
| 288 | ||||||
| 289 | ||||||
| 290 | ||||||
| 291 | ||||||
| 292 | ||||||
| 293 | ||||||
| 294 | ||||||
| 295 | ||||||
| 296 | ||||||
| 297 | ||||||
| 298 | ||||||
| 299 | ||||||
| 300 | ||||||
| 301 | ||||||
| 302 | ||||||
| 303 | ||||||
| 304 | ||||||
| 305 | ||||||
| 306 | ||||||
| 307 | ||||||
| 308 | ||||||
| 309 | ||||||
| 310 | ||||||
| 311 | ||||||
| 312 | ||||||
| 313 | ||||||
| 314 | ||||||
| 315 | ||||||
| 316 | ||||||
| 317 | ||||||
| 318 | ||||||
| 319 | ||||||
| 320 | ||||||
| 321 | ||||||
| 322 | ||||||
| 323 | ||||||
| 324 | ||||||
| 325 | ||||||
| 326 | ||||||
| 327 | ||||||
| 328 | ||||||
| 329 | ||||||
| 330 | ||||||
| 331 | ||||||
| 332 | ||||||
| 333 | ||||||
| 334 | ||||||
| 335 | ||||||
| 336 | ||||||
| 337 | ||||||
| 338 | ||||||
| 339 | ||||||
| 340 | ||||||
| 341 | ||||||
| 342 | ||||||
| 343 | ||||||
| 344 | ||||||
| 345 | ||||||
| 346 | ||||||
| 347 | ||||||
| 348 | ||||||
| 349 | ||||||
| 350 | ||||||
| 351 | ||||||
| 352 | ||||||
| 353 | ||||||
| 354 | ||||||
| 355 | ||||||
| 356 | ||||||
| 357 | ||||||
| 358 | ||||||
| 359 | ||||||
| 360 | ||||||
| 361 | ||||||
| 362 | ||||||
| 363 | ||||||
| 364 | ||||||
| 365 | ||||||
| 366 | ||||||
| 367 | ||||||
| 368 | ||||||
| 369 | ||||||
| 370 | ||||||
| 371 | ||||||
| 372 | ||||||
| 373 | ||||||
| 374 | ||||||
| 375 | ||||||
| 376 | ||||||
| 377 | ||||||
| 378 | ||||||
| 379 | ||||||
| 380 | ||||||
| 381 | ||||||
| 382 | ||||||
| 383 | ||||||
| 384 | ||||||
| 385 | ||||||
| 386 | ||||||
| 387 | ||||||
| 388 | ||||||
| 389 | ||||||
| 390 | ||||||
| 391 | ||||||
| 392 | ||||||
| 393 | ||||||
| 394 | ||||||
| 395 | ||||||
| 396 | ||||||
| 397 | ||||||
| 398 | ||||||
| 399 | ||||||
| 400 | ||||||
| 401 | ||||||
| 402 | ||||||
| 403 | ||||||
| 404 | ||||||
| 405 | ||||||
| 406 | ||||||
| 407 | ||||||
| 408 | ||||||
| 409 | ||||||
| 410 | ||||||
| 411 | ||||||
| 412 | ||||||
| 413 | ||||||
| 414 | ||||||
| 415 | ||||||
| 416 | ||||||
| 417 | ||||||
| 418 | ||||||
| 419 | ||||||
| 420 | ||||||
| 421 | ||||||
| 422 | ||||||
| 423 | ||||||
| 424 | ||||||
| 425 | ||||||
| 426 | ||||||
| 427 | ||||||
| 428 | ||||||
| 429 | ||||||
| 430 | ||||||
| 431 | ||||||
| 432 | ||||||
| 433 | ||||||
| 434 | ||||||
| 435 | ||||||
| 436 | ||||||
| 437 | ||||||
| 438 | ||||||
| 439 | ||||||
| 440 | ||||||
| 441 | ||||||
| 442 | ||||||
| 443 | ||||||
| 444 | ||||||
| 445 | ||||||
| 446 | ||||||
| 447 | ||||||
| 448 | ||||||
| 449 | ||||||
| 450 | ||||||
| 451 | ||||||
| 452 | ||||||
| 453 | ||||||
| 454 | ||||||
| 455 | ||||||
| 456 | ||||||
| 457 | ||||||
| 458 | ||||||
| 459 | ||||||
| 460 | ||||||
| 461 | ||||||
| 462 | ||||||
| 463 | ||||||
| 464 | ||||||
| 465 | ||||||
| 466 | ||||||
| 467 | ||||||
| 468 | ||||||
| 469 | ||||||
| 470 | ||||||
| 471 | ||||||
| 472 | ||||||
| 473 | ||||||
| 474 | ||||||
| 475 | ||||||
| 476 | ||||||
| 477 | ||||||
| 478 | ||||||
| 479 | ||||||
| 480 | ||||||
| 481 | ||||||
| 482 | ||||||
| 483 | ||||||
| 484 | ||||||
| 485 | ||||||
| 486 | ||||||
| 487 | ||||||
| 488 | ||||||
Selling compounded glp-1s? See the answers you are losing.
The free AI Visibility Audit maps every question above to your brand: where you show up, where competitors win, and which sources decide it.
Visibility by engine
Share of each engine's answers mentioning the brand, latest day.
| Brand | ChatGPT | Claude | Perplexity | Google AI |
|---|---|---|---|---|
| Hims & Hers | 33% | 89% | 0% | 100% |
| Ro | 44% | 67% | 0% | 0% |
| Novo Nordisk | 56% | 44% | 0% | 0% |
| LifeMD | 0% | 67% | 0% | 0% |
| GoodRx | 44% | 22% | 0% | 0% |
| Henry Meds | 0% | 56% | 0% | 0% |
| PlushCare | 44% | 0% | 0% | 0% |
| Eli Lilly | 33% | 11% | 0% | 0% |
Most cited sources
The sites AI engines lean on when answering compounded glp-1s questions. This is where AI visibility is won.
- goodrx.com161
- fda.gov106
- reddit.com85
- policylab.us72
- pmc.ncbi.nlm.nih.gov62
- facebook.com54
- vaccinealliance.org52
- brownhealth.org45
Tracked buyer intent questions
The full set of 15customer questions for this category. Three run each day in rotation, so the whole set is covered every five days. Today's three are highlighted.
- discoveryWhat is compounded semaglutide and where can I get it?
- discoveryWhich companies sell compounded GLP-1 weight loss medication online?
- qualifiedIs compounded tirzepatide still available anywhere legitimate?
- comparisonCompounded semaglutide vs brand name Wegovy: what is the real difference?
- pricingHow much does compounded semaglutide cost per month compared to Wegovy?
- validationIs compounded semaglutide safe? How do I avoid sketchy providers?
- qualifiedWhich compounded GLP-1 providers use licensed US pharmacies?
- comparisonWhat are the most reputable compounded GLP-1 programs right now?
- pricingWhat is the cheapest legitimate way to get a GLP-1 medication online?
- discoveryMy insurance denied Wegovy. Are compounded GLP-1s my best option?
- validationHow can I tell if an online compounded semaglutide pharmacy is FDA compliant?
- switchingMy compounded semaglutide provider shut down. Where should I move my treatment?
- comparisonCompounded GLP-1 drops or tablets vs injections: do the oral versions work?Today
- qualifiedWhich telehealth services still offer compounded GLP-1s after the FDA crackdown?Today
- validationWhat happened with the FDA and compounded GLP-1s, and who is still operating legally?Today
Recent AI answers
FDA & Compounded GLP-1s: What Happened The Core Issue The FDA declared semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) shortages officially over in early-mid 2025. Under federal law, compounding pharmacies can only make copies of brand-name drugs during official shortages. What This Means 503B outsourcing facilities had to stop producing large-scale compounded semaglutide/tirzepatide 503A compounding pharmacies (which fill individual prescriptions) faced similar restrictions The FDA sent warning letters to pharmacies continuing to compound these medications illegally Who Is Still Operating Legally Legitimate options remaining: Hims & Hers - pivoted to FDA-approved branded versions and personalized/combination formulations (different legal pathway) Ro - similarly shifted toward branded medications LifeMD / Henry Meds - prescribing branded versions with manufacturer savings programs Nuvation/local 503A pharmacies - some still compound if they can demonstrate a specific patient need or use slightly altered formulations Important Caveats This space changes rapidly — always verify current legal status Be cautious of any telehealth company still advertising cheap compounded semaglutide Manufacturer savings cards (Novo Nordisk, Eli Lilly) can significantly reduce branded drug costs Always consult your doctor and verify a pharmacy's 503 status before purchasing.
Read full answer with sources →Short answer: I don’t have a reliable, up‑to‑the‑minute list of telehealth services that still supply compounded GLP‑1 products — and for safety/regulatory reasons most reputable telehealth companies stopped offering compounded GLP‑1s after the FDA warnings. If you’re looking for GLP‑1 treatment, it’s safer to work with a telehealth provider that prescribes FDA‑approved GLP‑1 medicines (Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound) rather than seeking compounded versions. Services to consider (they prescribe FDA‑approved GLP‑1s and use licensed prescribers) PlushCare — national telehealth primary‑care/urgent‑care provider that evaluates and prescribes weight‑loss or diabetes medications when appropriate. Good for ongoing follow up. Hims & Hers — has offered GLP‑1 programs through licensed clinicians and is set up as a direct telehealth/retail model. Ro (including their weight‑loss/Zero services) — provides telehealth evaluation and prescriptions for FDA‑approved weight‑loss meds. GoodRx Care / NowRx telehealth partners — can connect you to clinicians who may prescribe FDA‑approved GLP‑1s and provide pharmacy options. Local health‑system telehealth (e.g., One Medical, large hospital systems’ telemedicine clinics) — often safer because they integrate with your medical records. Why these are better than compounded GLP‑1s They prescribe FDA‑approved, clinically tested products with known quality, dosing, and safety profiles. Licensed clinicians provide evaluation and follow‑up. Less risk of contamination, incorrect potency, or adulterated products. If you still want a telehealth+compounding route (be cautious) Ask the telehealth service to name the compounding pharmacy and verify: State pharmacy license and whether it’s a 503A (patient‑specific) or 503B (outsourcing) facility. PCAB accreditation or other quality accreditations. USP <795>/<797> or <800> compliance for sterile compounding if injectable. Whether they provide a Certificate of Analysis (COA) or independent lab testing for each batch. Where the product is shipped from and which prescriber signed the prescription. Check state pharmacy board and NABP records for the pharmacy and the prescriber. Why I’m cautious The FDA has warned many compounded GLP‑1 products are adulterated or misbranded and may pose safety risks. Some compounding pharmacies were subject to enforcement. Buying compounded injectable GLP‑1s that are not made under strict sterile and quality controls can be dangerous. If your goal is affordability or access during shortage: Ask clinicians about manufacturer coupons, patient‑assistance programs, lower‑cost formulations (e.g., oral Rybelsus where appropriate), or authorized pharmacy alternatives. Discuss clinical suitability of an FDA‑approved option with a clinician rather than using an unverified compounded product. If you want, tell me: your state (laws and availability vary), and whether you want a telehealth visit that leads to an FDA‑approved prescription or you specifically want information on compounding pharmacies — I can then give more targeted guidance on how to verify a provider safely.
Read full answer with sources →Short answer: most compounded “GLP‑1 drops or tablets” are not reliable and I do not recommend them. Use FDA‑approved products (oral semaglutide — Rybelsus — or one of the injectable GLP‑1/GIP drugs such as Ozempic, Wegovy, Mounjaro/Zepbound) or work with your clinician to find an approved, safe alternative. Why compounded oral GLP‑1 products are risky and usually ineffective GLP‑1 drugs are peptides that are destroyed in the stomach/intestine and have very low oral bioavailability unless formulated specifically to be absorbed. Rybelsus (oral semaglutide) is the only widely approved oral GLP‑1; it uses a proprietary absorption enhancer (SNAC) and has been studied in clinical trials. Compounded drops/tablets generally lack validated formulation, absorption data, stability testing or dose‑equivalence to the approved drugs. Compounded products from unverified pharmacies can vary in potency, may be contaminated, and have no guarantee of sterility or consistent dosing. There are anecdotal reports of benefit, but no reliable randomized data proving safety or efficacy for these formulations. Injectables (Ozempic and Wegovy — semaglutide; Mounjaro/Zepbound — tirzepatide; Saxenda — liraglutide) have robust clinical-trial evidence showing greater and more consistent glucose control and weight loss than what you should expect from an untested compounded oral product. What works and why Rybelsus (oral semaglutide): FDA‑approved oral GLP‑1 with clinical evidence for lowering A1c and modest weight loss. It must be taken on an empty stomach with a small sip of water and you must wait ~30 minutes before eating other meds/food for adequate absorption. Injectable GLP‑1/GIP drugs (Ozempic, Wegovy, Mounjaro/Zepbound, Saxenda): proven in multiple large trials to produce larger reductions in weight and blood glucose than oral semaglutide. They have predictable dosing and monitored safety data. If cost or access is the issue Talk to your prescriber about Rybelsus first (if you want oral). If injections are recommended, ask about patient savings programs or coupons from manufacturers (e.g., Novo Nordisk for Wegovy/Ozempic, Eli Lilly for Mounjaro/Zepbound). GoodRx or your insurer’s specialty-pharmacy network can help with pricing. If a pharmacy suggests a “cheaper” compounded oral version, ask for written stability/bioavailability data and verify the compounding pharmacy is PCAB‑accredited — but even then the product won’t be FDA‑approved or proven. Safety reminders GLP‑1s commonly cause nausea, vomiting, diarrhea; rare but serious risks include pancreatitis and possible thyroid C‑cell tumor signals seen in animals (contraindicated in patients with medullary thyroid carcinoma or MEN2). Always discuss medical history and medications with your clinician before starting any GLP‑1. If you’re offered a compounded product and experience an adverse event, seek medical care and report it to your provider and the appropriate regulatory agency. Practical next steps Discuss with your primary care doctor or an endocrinologist which FDA‑approved option fits your goals (Rybelsus vs injectable agents). If cost is a blocker, ask about manufacturer assistance, specialty pharmacy options, or clinical trials. Avoid off‑label compounded oral versions unless you have a compelling, documented reason and you fully understand the unknowns and risks. If you want, tell me whether your goal is diabetes control or weight loss, any medical issues/medications you’re on, and whether cost/access is a concern — I can suggest which approved product is most appropriate and point you to assistance programs.
Read full answer with sources →Compounded GLP-1 Oral Forms vs. Injections Short answer: The oral/sublingual versions are largely unproven and likely far less effective than injections. Why Injections Work Better GLP-1 medications like semaglutide work because they survive in the bloodstream long enough to reach receptors throughout the body. When taken orally or sublingually: Digestive enzymes break down peptides rapidly Absorption through mouth tissue is minimal for large peptide molecules Bioavailability is drastically lower than subcutaneous injection What's Actually Available (Legitimately) Proven oral option: Ozempic/Rybelsus – Novo Nordisk's oral semaglutide uses a specific absorption enhancer (SNAC) and requires very precise dosing protocols. Even then, bioavailability is ~1% vs injections. Compounded injectables with some evidence: Compounded semaglutide or tirzepatide injections from licensed compounding pharmacies (like Empower Pharmacy or Hallandale Health) mirror the injection mechanism Red Flags to Avoid Sublingual "semaglutide drops" sold online Oral capsules from telehealth companies making bold claims Products without verified third-party testing Bottom Line Stick with injections if you want results consistent with clinical trials. If needles are a concern, ask your doctor about Rybelsus (legitimate oral semaglutide), understanding it requires strict protocols to work at all. Always use an FDA-registered compounding pharmacy and work with a licensed prescriber.
Read full answer with sources →This is a fast-moving situation, so I want to be straightforward with you: What Happened The FDA declared the semaglutide shortage over (early 2025), meaning compounding pharmacies can no longer legally make copies of branded GLP-1s like Ozempic/Wegovy under the same rules as before. Services Still Navigating This Space Hims & Hers - Was offering compounded semaglutide but faced significant legal/regulatory pressure and adjusted their offerings. Ro - Similar situation; pulled back on compounded semaglutide. LifeMD - Has been working to transition patients to branded options. Sesame - Connects you with doctors who may discuss alternatives. Honest Caveats I'd Give You The situation changes weekly - what's available today may not be tomorrow Some services are offering "personalized" formulations (like semaglutide + B12) that exist in a legal gray area FDA has warned consumers about safety risks with some compounded versions Any service currently promising easy access to compounded semaglutide may be operating in legally questionable territory My Recommendation Check GoodRx or NovoCare for branded medication assistance programs, or ask your regular doctor about manufacturer savings programs, which can significantly reduce costs legally. Would you like help thinking through alternatives?
Read full answer with sources →